Ping An Good Doctor (1833.HK) - A Vicious Cycle?
Xinyao has highlighted this Insight as a Top Pick
190 Views30 Aug 2021 09:26
This article mainly analyzed Ping An Good Doctor in terms of its performance in 2021/1H, the business and the underlying logic, the comparison with peers, the concerns and the outlook of the Company.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
Price Chart(Sign Up to Access)
- JD Health (6618.HK) 2021 Results - The Logic and the Outlook06 Apr 2022
- Pre-IPO ClouDr Group - The Logical Business Model Can Support Future Growth24 Feb 2022
- Pre-IPO Medbanks Network Technology - Conservative About the Outlook27 Jan 2022
- Ping An Good Doctor (1833.HK) - A Vicious Cycle?30 Aug 2021
- Pre-IPO Dingdang Health Technology - The Future Looks Challenging27 Jul 2021
- Ping An Good Doctor (1833.HK) - It Is the Time to Look at Some Concerns22 Feb 2021
- JD Health (6618.HK) - Opportunities Coexist with Challenges15 Dec 2020
x